Compare HROW & PDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HROW | PDS |
|---|---|---|
| Founded | 1998 | 1951 |
| Country | United States | Canada |
| Employees | 373 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | N/A | 1998 |
| Metric | HROW | PDS |
|---|---|---|
| Price | $42.21 | $83.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $69.86 | ★ $122.33 |
| AVG Volume (30 Days) | ★ 752.2K | 78.7K |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $31.62 | $5.66 |
| Revenue Next Year | $50.77 | $2.31 |
| P/E Ratio | ★ N/A | $884.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.54 | $48.59 |
| 52 Week High | $54.98 | $103.80 |
| Indicator | HROW | PDS |
|---|---|---|
| Relative Strength Index (RSI) | 71.20 | 36.26 |
| Support Level | $40.61 | $55.33 |
| Resistance Level | $51.01 | $102.00 |
| Average True Range (ATR) | 2.10 | 3.85 |
| MACD | 1.07 | -1.20 |
| Stochastic Oscillator | 96.39 | 11.72 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
Precision Drilling Corp is a provider of contract drilling, completion, and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. The company operates through two industry segments: Contract Drilling Services, which generates maximum revenue and includes drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale, and repair of drilling equipment; and Completion and Production Services, which includes service rigs, oilfield equipment rental, and camp services. The company generates the majority of its revenue from the United States.